| 前收市價 | 0.5000 |
| 開市 | 0.5000 |
| 買盤 | 0.0000 |
| 賣出價 | 0.7500 |
| 拍板 | 35.00 |
| 到期日 | 2024-08-16 |
| 今日波幅 | 0.5000 - 0.5000 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 40 |
ZacksMyriad Genetics (MYGN) and GSK Unite to Boost HRD Testing
Myriad Genetics (MYGN) collaborates with GSK to improve access to HRD diagnostic testing for HGSOC patients.
ZacksMyriad Genetics (MYGN) Banks on Innovation Amid Macro Woes
Myriad Genetics (MYGN) continues to enhance its customer targeting, digital marketing and overall operating model to drive commercial leverage in 2024 and beyond.
ZacksMyriad (MYGN) Down 5.2% Since Last Earnings Report: Can It Rebound?
Myriad (MYGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
